Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present ProtoKinetix, Inc. (OTC: PKTX).

Full DD Report for PKTX

You must become a subscriber to view this report.



Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-140.0780.0750.0780.07549,723
2018-12-130.0740.070.0740.0780,450
2018-12-120.0840.0840.0840.084600
2018-12-110.0750.08490.08490.07574,000
2018-12-10N/A0.085N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1444,22349,72388.9387Short
2018-12-1372,20080,45089.7452Short
2018-12-1172,55074,00098.0405Short
2018-12-0714,82342,52334.8588Cover
2018-12-0610,00010,000100.0000Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on PKTX.


About ProtoKinetix, Inc. (OTC: PKTX)

Logo for ProtoKinetix, Inc. (OTC: PKTX)

lt p gt ProtoKinetix, Incorporated ProtoKinetix or the Company is a research and development stage biotechnology company focused on scientific medical research of AFGPs Anti Freeze Glycoproteins or anti aging glycoproteins, and has developed and patented a family of hyper stable, potent glycopeptides trademarked as AAGPs that enhance the therapeutic results and can reduce the cost of stem cell medicine. Due to the anti inflammatory effect of AAGPTM molecules, the Company is currently in the process of directing major efforts to target the direct treatment of diseases that have a major inflammatory component. lt /p gt

 

Contact Information

 

 

Current Management

  • Clarence E. Smith / CEO, President
  • Michael Guzzetta / CFO
  • Clarence E. Smith / Chairman
  • Edward P. McDonough /

Current Share Structure

  • Market Cap: $14,518,565 - 03/09/2018
  • Authorized: 400,000,000 - 02/28/2018
  • Issue and Outstanding: 254,711,673 - 02/28/2018
  • Float: 138,759,876 - 05/28/2015

 


Recent Filings from (OTC: PKTX)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: April, 26 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 10 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: January, 22 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: January, 17 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: November, 15 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 13 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: November, 09 2017
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act
Filing Type: DFiling Source: edgar
Filing Date: September, 21 2017
Amendment to a previously filed 8-K
Filing Type: 8-K/AFiling Source: edgar
Filing Date: September, 12 2017

 

 


Daily Technical Chart for (OTC: PKTX)

Daily Technical Chart for (OTC: PKTX)


Stay tuned for daily updates and more on (OTC: PKTX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: PKTX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in PKTX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of PKTX and does not buy, sell, or trade any shares of PKTX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/